Share
Afsaneh Lavasanifar is using nanotechnology to develop precise ways of delivering anti-cancer drugs to tumours, which could improve outcomes for patients while reducing side-effects of treatment. (Photo: Richard Siemens; taken pre-COVID-19)
A University of Alberta researcher is using nanotechnology to improve the effectiveness of chemotherapy treatments for cancer patients and reduce their side-effects.
Afsaneh Lavasanifar is a professor in the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Sciences and an adjunct professor in the Department of Chemical and Medical Engineering. Her lab develops precision health solutions through nanomedicine, finding ways to deliver drug-loaded nanoparticles to tumour sites.
“In nanomedicine, we are either working to improve the effectiveness of drugs that are already on the market or making new and better drugs by using (delivery) ‘vehicles’ that are in the nanometre-size range,” explained Lavasanifar. “These vehi
Date Time
Researcher uses nanomedicine to improve effectiveness and safety of chemotherapy
A University of Alberta researcher is using nanotechnology to improve the effectiveness of chemotherapy treatments for cancer patients and reduce their side-effects.
Afsaneh Lavasanifar is a professor in the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Sciences and an adjunct professor in the Department of Chemical and Medical Engineering. Her lab develops precision health solutions through nanomedicine, finding ways to deliver drug-loaded nanoparticles to tumour sites.
“In nanomedicine, we are either working to improve the effectiveness of drugs that are already on the market or making new and better drugs by using (delivery) ‘vehicles’ that are in the nanometre-size range,” explained Lavasanifar. “These vehicles either make the drugs more effective or reduce their side-effects, or both.”
Date Time
Scientists Create First-of-its-Kind 3D Organoid Model of Human Pancreas
New Research Platform Will Shed Light on the Early Stages of Pancreatic Cancer and Could Open the Door to Life-Saving Screening
Boston – This year, more than 60,000 adults in the United States will be diagnosed with pancreatic cancer and, statistically, as few as 10 percent will survive five years after diagnosis, according to the American Cancer Society. Because pancreatic cancer is hidden deep within the body and often symptomless, it’s frequently diagnosed after the disease has progressed too far for surgical intervention and/or has spread throughout the body. Research indicates that earlier detection of pancreatic tumors could quadruple survival rates; however, no validated and reliable tests for early detection of pancreatic cancer currently exist.
E-Mail
Boston - This year, more than 60,000 adults in the United States will be diagnosed with pancreatic cancer and, statistically, as few as 10 percent will survive five years after diagnosis, according to the American Cancer Society. Because pancreatic cancer is hidden deep within the body and often symptomless, it s frequently diagnosed after the disease has progressed too far for surgical intervention and/or has spread throughout the body. Research indicates that earlier detection of pancreatic tumors could quadruple survival rates; however, no validated and reliable tests for early detection of pancreatic cancer currently exist.
Now, researchers at the Cancer Research Institute at Beth Israel Deaconess Medical Center (BIDMC) have successfully created the first three-dimensional (3D) organoid models of the pancreas from human stem cells. Unlike previous platforms for the study of pancreatic cancer, this first-of-its-kind organoid model includes both the acinar and ductal st
Cumhurbaşkanlığı Külliyesinde aşı zirvesi! internethaber.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from internethaber.com Daily Mail and Mail on Sunday newspapers.